Back to Search
GHASSAN ABOU-ALFA, MD
MD
Medical Oncology Physician
NPI: 1134190168IndividualAccepts Medicare
Education
OTHER
Class of 1992
Research & Publications (20)
Commentary: Sorafenib -- the end of a long journey in search of systemic therapy for hepatocellular carcinoma, or the beginning?
PMID 19144679·Oncologist·2009
8-other
Selection of patients with hepatocellular carcinoma for sorafenib.
PMID 19406040·J Natl Compr Canc Netw·2009
6-review
The impact of new data in the treatment of advanced hepatocellular carcinoma.
PMID 18765149·Curr Oncol Rep·2008
6-review
Current management of advanced hepatocellular carcinoma.
PMID 19259298·Gastrointest Cancer Res·2008
8-other
Treatment of hepatocellular carcinoma: considerations regarding etiology and molecular biology.
PMID 19360155·Gastrointest Cancer Res·2007
8-other
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
PMID 16983112·J Clin Oncol·2006
3-trial
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.
PMID 16062073·Am J Clin Oncol·2005
3-trial
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.
PMID 16908937·J Clin Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1134190168
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile